ERBB2 and breast carcinoma: The pathology of consecutive breast cancers related to those variants were estrogen receptor-positive as typically described for BRCA2 breast tumors (Supplementary Table 2; 29/35 ER-positive, 32/35 PR-positive, 4/18 HER2-positive, 10/25 grade 2) [39].